Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Treatment options for metastatic melanoma are limited. Here the authors show that combining an immunostimulant adenovirus, currently in clinical trials for leukemia, with immune checkpoints blockade (ICB) results in systemic eradication of ICB resistant melanoma tumours from both skin and brain of m...
Saved in:
Main Authors: | Manisha Singh, Christina Vianden, Mark J. Cantwell, Zhimin Dai, Zhilan Xiao, Meenu Sharma, Hiep Khong, Ashvin R. Jaiswal, Faisal Faak, Yared Hailemichael, L. M. E. Janssen, Uddalak Bharadwaj, Michael A. Curran, Adi Diab, Roland L. Bassett, David J. Tweardy, Patrick Hwu, Willem W. Overwijk |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/91b84c7ca48048a5926a4f18a85bbaa3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
by: Meenu Sharma, et al.
Published: (2020) -
Trial watch: intratumoral immunotherapy
by: Juliette Humeau, et al.
Published: (2021) -
Intratumoral heterogeneity and clonal evolution in liver cancer
by: Bojan Losic, et al.
Published: (2020) -
Clinical significance of intratumor heterogeneity for gynecological carcinoma
by: Ying-Chao Yang, et al.
Published: (2015) -
Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
by: Sharanya Maanasi Kalasekar, et al.
Published: (2021)